SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001078782-21-000365
Filing Date
2021-04-15
Accepted
2021-04-15 16:01:23
Documents
9
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ANNUAL REPORT f10k123120_10k.htm 10-K 1046739
2 EXHIBIT 23.1 AUDITOR'S CONSENT f10k123120_ex23z1.htm EX-23.1 609
3 EXHIBIT 31.1 SECTION 302 CERTIFICATION f10k123120_ex31z1.htm EX-31.1 8775
4 EXHIBIT 31.2 SECTION 302 CERTIFICATION f10k123120_ex31z2.htm EX-31.2 8870
5 EXHIBIT 32.1 SECTION 906 CERTIFICATION f10k123120_ex32z1.htm EX-32.1 3652
6 EXHIBIT 32.2 SECTION 906 CERTIFICATION f10k123120_ex32z2.htm EX-32.2 3479
7 IMAGE f10k123120ex23z1_1.jpg GRAPHIC 162176
8 IMAGE f10k12312010k_1.jpg GRAPHIC 31977
9 IMAGE f10k12312010k_2.jpg GRAPHIC 92185
  Complete submission text file 0001078782-21-000365.txt   1467013
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54296 | Film No.: 21828486
SIC: 2834 Pharmaceutical Preparations